IL1A and coronary artery disorder: Although many studies have shown the release of IL-1α and IL-1β on AMI experimental models, the increase in IL-1 plasma levels in AMI patients was not systematically highlighted, some studies showing values ​​comparable to those of patients without coronary disease [14].